PERCEPTIVE ADVISORS LLC Q1 2018 Filing
Filed May 15, 2018
Portfolio Value
$3.6T
Holdings
133
Report Date
Q1 2018
Filing Type
13F-HR
All Holdings (133 positions)
| Stock | Value |
|---|---|
NBIXNEUROCRINE BIOSCIENCES INC | $394.9B |
AM6AMICUS THERAPEUTICS INC | $301.2B |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $241.0B |
—ZOGENIX INC | $159.0B |
ALNYALNYLAM PHARMACEUTICALS | $152.5B |
—LA JOLLA PHARMACEUTICAL CO | $128.5B |
IOVAIOVANCE BIOTHERAPEUTICS INC | $104.1B |
ALXNALEXION PHARMACEUTICALS INC | $97.4B |
ABMDEURABIOMED INC | $96.7B |
2L9BLUEPRINT MEDICINES CORP | $94.5B |
—DOVA PHARMACEUTICALS INC | $75.4B |
—CORIUM INTERNATIONAL INC | $72.9B |
—RETROPHIN INC | $71.8B |
—BIOHAVEN PHARMACEUTICAL HLDG CO L | $71.2B |
ASNDASCENDIS PHARMA A S | $64.3B |
CTMXCYTOMX THERAPEUTICS INC | $62.8B |
—MENLO THERAPEUTICS INC | $60.1B |
XLRNACCELERON PHARMA INC | $59.3B |
BDQMALBIREO PHARMA INC | $55.5B |
—DBV TECHNOLOGIES S A | $48.3B |
MMSIMERIT MED SYS INC | $47.4B |
ARGXARGENX SE-ADR | $43.2B |
—MYOKARDIA INC | $40.7B |
XNCRXENCOR INC | $39.5B |
—AVEXIS INC | $34.2B |
VAC2USDVBI VACCINES INC | $33.8B |
CBAYUSDCYMABAY THERAPEUTICS INC | $33.7B |
QUREUNIQURE NV | $32.8B |
PBYIPUMA BIOTECHNOLOGY INC | $31.7B |
—SOLID BIOSCIENCES INC | $29.5B |
—QUOTIENT LTD | $28.4B |
IRTCIRHYTHM TECHNOLOGIES INC | $26.4B |
RGNXREGENXBIO INC | $26.3B |
VRTXVERTEX PHARMACEUTICALS INC | $24.8B |
ANABANAPTYSBIO INC | $24.7B |
—NEPTUNE TECHNOLOGIES BIORESO | $24.1B |
AKBAAKEBIA THERAPEUTICS INC | $23.5B |
ASMBASSEMBLY BIOSCIENCES INC | $23.4B |
ALDXALDEYRA THERAPEUTICS INC | $23.1B |
—AUDENTES THERAPEUTICS INC | $22.7B |
—KADMON HLDGS INC | $22.0B |
TDOCTELADOC INC | $21.0B |
GLPGGALAPAGOS N V | $20.6B |
AGIOAGIO PHARMACEUTICALS INC | $20.4B |
—ABLYNX NV | $20.2B |
—ENDOCYTE INC | $20.0B |
RVNCEURREVANCE THERAPEUTICS INC | $19.1B |
WVEWAVE LIFE SCIENCES LTD | $18.6B |
ADMAADMA BIOLOGICS INC | $17.6B |
MDGLMADRIGAL PHARMACEUTICALS INC | $16.6B |
HUMHUMANA INC | $16.3B |
—ADAMAS PHARMACEUTICALS INC | $15.1B |
—PORTOLA PHARMACEUTICALS INC | $14.5B |
—ABEONA THERAPEUTICS INC | $14.2B |
—MOTUS GI HLDGS INC | $12.6B |
—ABEONA THERAPEUTICS INC | $12.0B |
RYTMRHYTHM PHARMACEUTICALS INC | $11.8B |
TFXTELEFLEX INC | $10.4B |
—SIERRA ONCOLOGY INC | $10.3B |
CLLSCELLECTIS S A | $9.5B |
AVDLAVADEL PHARMACEUTICALS PLC | $9.4B |
INCYINCYTE CORP | $9.2B |
—AGILE THERAPEUTICS INC | $9.1B |
—SYNLOGIC INC | $8.8B |
NVTA1EURINVITAE CORP | $8.7B |
—ONCOMED PHARMACEUTICALS INC | $8.3B |
CDNACAREDX INC | $8.3B |
—ANI PHARMACEUTICALS INC | $8.2B |
PTCTPTC THERAPEUTICS INC | $8.1B |
—ZYMEWORKS INC | $7.8B |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $7.7B |
—AVEO PHARMACEUTICALS INC | $7.1B |
—FLEXION THERAPEUTICS INC | $6.9B |
ARNAEURARENA PHARMACEUTICALS INC | $6.8B |
ACADACADIA PHARMACEUTICALS INC | $6.2B |
—HISTOGENICS CORP | $6.1B |
SELBUSDSELECTA BIOSCIENCES INC | $6.0B |
—MOLECULAR TEMPLATES INC | $5.8B |
—FOAMIX PHARMACEUTICALS LTD | $5.7B |
BIIBBIOGEN INC | $5.5B |
—NUVECTRA CORP | $5.0B |
ISRGINTUITIVE SURGICAL INC | $4.1B |
—ACHILLION PHARMACEUTICALS INC | $3.7B |
IVCUSDINVACARE CORP | $3.5B |
—MARINUS PHARMACEUTICALS INC | $3.5B |
ATNXEURATHENEX INC | $3.2B |
—ODONATE THERAPEUTICS INC | $3.2B |
—ALLENA PHARMACEUTICALS INC | $2.8B |
ARWRARROWHEAD PHARMACEUTICALS INC | $2.6B |
—ADVAXIS INC | $2.5B |
—AKCEA THERAPEUTICS INC | $2.5B |
—STRONGBRIDGE BIOPHARMA PLC | $2.4B |
MCKMCKESSON CORP | $2.1B |
—VICAL INC | $1.7B |
CLDNEUREIGER BIOPHARMACEUTICALS INC | $1.6B |
XBISPDR SERIES TRUST | $1.5B |
ITCIEURINTRA CELLULAR THERAPIES INC | $1.5B |
GYRECATALYST BIOSCIENCES IINC | $1.4B |
CSBRCHAMPIONS ONCOLOGY INC | $1.3B |
STLAFIAT CHRYSLER AUTOMOBILES N | $1.3B |
Page 1 of 2Next